Cor Vasa 2023, 65(6):832-835 | DOI: 10.33678/cor.2023.063

Clinical and Demographic Properties of Candida Endocarditis in a Tertiary Heart Center

Sibel Doğan Kaya, Yeşim Uygun Kizmaz
Infectious Diseases and Clinical Microbiology Department, Kosuyolu High Specialization Training and Research Hospital, Istanbul, Turkey

Background: Candida is a rare but important cause of infective endocarditis. The study aimed to describe clinical data on patients with Candida endocarditis treated in cardiology and cardiovascular surgery hospital between 2012-2023.

Methods: Patients diagnosed with infective endocarditis were reviewed retrospectively. Demographic information, medical histories, clinical data, and information on outcome and treatment were presented.

Results: Four (29%) of 14 patients were female, and 10 (71%) were male. The mean age was 49.7 (±8.82) years. The mean hospital stay was 39 days (33-130 days). The valves involved were 5 (38%) aortic valves, 2 (15%) aortic + mitral valves, 3 (23%) mitral valves, 2 (16%) vegetation on the lead, and 1 (7%) in the pulmonary valve. In the underlying diseases, 5 (35%) had diabetes mellitus, 5 (35%) had hemodialysis, and 4 (30%) had pacemakers. One (7%) of the patients had a heart transplant, and 1 had a liver transplant. Seven (50%) had a prosthetic valve, and 7 (50%) had a natural valve. The detected microbiological factors are: 8 (57%) had Candida parapsilosis (C. parapsilosis), 5 (35%) Candida albicans (C. albicans ) and 1 (7%) Candida tropicalis (C. tropicalis). There was a valve change in 7 (50%) of them. C. albicans grew in the valve culture of one patient. Fluconazole was used in 6 patients (43%), and echinocandins were used in 8 (57%) patients. Six patients (43%) died during 1-year follow-up. Embolism in the central nervous system was detected in 6 patients (43%) on magnetic resonance imaging (MRI).

Conclusions: Candida endocarditis has a high mortality, and it is not easy to define the most appropriate treatment because of its rarity.

Keywords: Candida spp., Endocarditis, Infective endocarditis

Received: July 17, 2023; Revised: July 17, 2023; Accepted: August 5, 2023; Prepublished online: June 2, 2012; Published: December 22, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Doğan Kaya S, Kizmaz YU. Clinical and Demographic Properties of Candida Endocarditis in a Tertiary Heart Center. Cor Vasa. 2023;65(6):832-835. doi: 10.33678/cor.2023.063.
Download citation

References

  1. Pasha AK, Lee JZ, Low SW, Desai H, Lee KS, Al Mohajer M. Fungal Endocarditis: Update on Diagnosis and Management. Am J Med 2016;129:1037-1043. Go to original source... Go to PubMed...
  2. Yuan SM. Fungal Endocarditis. Braz J Cardiovasc Surg 2016;31:252-255. Go to original source...
  3. Pierrotti LC, Baddour LM. Fungal endocarditis, 1995-2000. Chest 2002;122:302-310. Go to original source... Go to PubMed...
  4. Nasser RM, Melgar GR, Longworth DL, Gordon SM. Incidence and risk of developing fungal prosthetic valve endocarditis after nosocomial candidemia. Am J Med 1997;103:25-32. Go to original source... Go to PubMed...
  5. Elamragy A, Meshaal MA, El-Kholy A A, et al. Gender differences in clinical features and complications of infective endocarditis: 11-year experience of a single institute in Egypt. Egypt Heart J 2020;72:5. Go to original source... Go to PubMed...
  6. Kaki R, Al-Abdullah N. Descriptive epidemiological, clinical and microbiological features of infective endocarditis at a University Hospital in Saudi Arabia. Am J Infect Dis 2019;14:63-68. Go to original source...
  7. Yombi JC, Yuma SN, Pasquet A, et al. Staphylococcal versus Streptococcal infective endocarditis in a tertiary hospital in Belgium: epidemiology, clinical characteristics and outcome. Acta Clin Belg 2017;72:417-423. Go to original source... Go to PubMed...
  8. Kuijpers JM, Koolbergen DR, Groenink M, et al. Incidence, risk factors, and predictors of infective endocarditis in adult congenital heart disease: focus on the use of prosthetic material. Eur Heart J 2017;38:2048-2056. Go to original source... Go to PubMed...
  9. Arnold CJ, Johnson M, Bayer AS, et al. Candida infective Endocarditis: an observational cohort study with a focus on therapy. Antimicrob Agents Chemother 2015;59:2365-2373. Go to original source... Go to PubMed...
  10. Maly J, Szarszoi O, Dorazilova Z, et al. Case report: atypical fungal obstruction of the left ventricular assist device outflow cannula. J Cardiothorac Surg 2014;9:40. Go to original source... Go to PubMed...
  11. Clancy CJ, Nguyen MH. Diagnosing invasive candidiasis. J Clin Microbiol 2018;56:e01909-e01917. Go to original source... Go to PubMed...
  12. Siciliano RF, Randi BA, Gualandro DM, et al. Early-onset prosthetic valve endocarditis. Prospective study and literature review. Int J Infect Dis 2018;67:3-6. Go to original source... Go to PubMed...
  13. Østergaard L, Valeur N, Ihlemann N ,et al. Incidence of infective endocarditis among patients considered at high risk. Eur Heart J 2018;39:623-629. Go to original source... Go to PubMed...
  14. Baddley JW, Benjamin DK, Patel M, et al. Candida infective endocarditis. Eur J Clin Microbiol Infect Dis 2008;27:519-529. Go to original source... Go to PubMed...
  15. Rivoisy C, Vena A, Schaeffer L, et al. Prosthetic Valve Candida spp. Endocarditis: New Insights Into Long-term Prognosis-The ESCAPE Study. Clin Infect Dis 2018;66:825-832. Go to original source... Go to PubMed...
  16. Siciliano RF, Gualandro DM, Sejas ONE, et al. Outcomes in patients with fungal endocarditis: a multicenter observational cohort study. Int J Infect Dis 2018;77:48-52. Go to original source... Go to PubMed...
  17. Giuliano S, Guastalegname M, Russo A, et al. Candida endocarditis: systematic literature review from 1997 to 2014 and analysis of 29 cases from the Italian Study of Endocarditis. Expert Rev Anti Infect Ther 2017;15:807-818. Go to original source... Go to PubMed...
  18. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation 2015;132:1435-1486. Go to original source... Go to PubMed...
  19. Miró JM, Puig de la Bellacasa J, Odds FC, et al. Systemic candidiasis in Spanish heroin addicts: a possible source of infection. J Infect Dis 1987;156:857-858. Go to original source... Go to PubMed...
  20. Bisbe J, Miró JM, Latorre X, et al. Disseminated candidiasis in addicts who use brown heroin: report of 83 cases and review. Clin Infect Dis 1992;15:910-923. Go to original source... Go to PubMed...
  21. Sankar NP, Thakarar K, Rokas KE. Candida Infective Endocarditis During the Infectious Diseases and Substance Use Disorder Syndemic: A Six-Year Case Series. Open Forum Infect Dis 2020;7:ofaa142. Go to original source... Go to PubMed...
  22. Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 2016;62:e1-e50. Go to original source... Go to PubMed...
  23. Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis. Eur Heart J 2015;36:3075-3128. Go to original source... Go to PubMed...
  24. Park LP, Chu VH, Peterson G, et al. Validated risk score for predicting 6-month mortality in infective Endocarditis. J Am Heart Assoc 2016;5:e003016. Go to original source... Go to PubMed...
  25. Pasupula DK, Bhat AG, Siddappa Malleshappa SK, et al. Trends and predictors of 30-day read mission among patients hospitalized with infective endocarditis in the United States. Cureus 2019;11:e4962. Go to original source... Go to PubMed...
  26. Bauer BK, Schulze AB, Löher A, et al. Candida tropicalis defibrillator endocarditis: a case reportand review of current literature. Med Mycol Case Rep 2019;25:1-9. Go to original source... Go to PubMed...
  27. Lejko Zupanc T, Logar M. Candida endocarditis: a review of twelve episodes in eleven patients. J Heart Valve Dis 2017;26:98-102.
  28. Ammannaya GKK, Sripad N. Fungal endocarditis: what do we know in 2019? Kardiol Pol 2019;77:670-673. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.





Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.